Literature DB >> 17068752

The development of China's medical biotech industry needs to be driven by innovation.

Zailin Yu1, Yuehan Dai.   

Abstract

The Chinese biotech industry is going through a period of fast growth, and with its huge population, China is predicted to be the biggest single-country market in the world. However, the Chinese biotech industry has to tackle the critical issue of innovation, which should be the driving force for China's development into an advanced and responsible country. Here, in this article, the authors review the history of the Chinese biotech industry, exemplified by the development of genetically engineered drugs during the last 20 years, and also point out its the future.

Mesh:

Year:  2006        PMID: 17068752     DOI: 10.1002/biot.200600086

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  2 in total

1.  Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.

Authors:  Yun-Zhen Shi; Hao Hu; Chunming Wang
Journal:  Global Health       Date:  2014-11-19       Impact factor: 4.185

Review 2.  Chinese health biotech and the billion-patient market.

Authors:  Sarah E Frew; Stephen M Sammut; Alysha F Shore; Joshua K Ramjist; Sara Al-Bader; Rahim Rezaie; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.